FDA says knockoff versions of Lilly obesity drug must come off the market - The Associated Press
- FDA says knockoff versions of Lilly obesity drug must come off the market The Associated Press
- FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next Yahoo Finance
- FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage CNBC